Table 4.
Number of subjects who were positive by screening FDG-PET and/or one or more of the combined screening tests if any
| Age group | Number | Rate (%) | Male | Rate (%) | Female | Rate (%) |
|---|---|---|---|---|---|---|
| 10–19 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| 20–29 | 55 | 5.5 | 13 | 2.7 | 42 | 7.9 |
| 30–39 | 653 | 7.3 | 285 | 5.6 | 368 | 9.6 |
| 40–49 | 2,194 | 8.4 | 1,027 | 6.5 | 1,167 | 11.2 |
| 50–59 | 5,240 | 10.2 | 2,900 | 9.5 | 2,340 | 11.2 |
| 60–69 | 5,876 | 12.3 | 3,592 | 12.2 | 2,284 | 12.5 |
| 70–79 | 2,437 | 14.5 | 1,427 | 14.4 | 1,010 | 14.6 |
| 80- | 402 | 15.9 | 261 | 17.5 | 141 | 13.5 |
| Unknown | 98 | 15.2 | ‐ | ‐ | – | ‐ |
| Total | 16,955 | 10.9 | 9,505 | 10.2 | 7,352 | 11.8 |